Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13

Kis Djamiatun1, Andre J A M van der Ven, Philip G de Groot

  • 1Department of Parasitology, Faculty of Medicine, Diponegoro University, Semarang, Indonesia.

Insights

Severe dengue involves Weibel-Palade body exocytosis, increasing von Willebrand factor (VWF) and osteoprotegerin (OPG) levels. Low ADAMTS-13 activity and high VWF activation contribute to dengue complications like thrombocytopenia.

Area of Science:

  • Hematology
  • Virology
  • Pathophysiology

Background:

  • Severe dengue, characterized by thrombocytopenia, bleeding, and plasma leakage, may involve endothelial cell activation and Weibel-Palade body (WPB) exocytosis.
  • Understanding the role of WPBs in dengue pathogenesis is crucial for managing severe disease manifestations.

Purpose of the Study:

  • To investigate the association between WPB exocytosis and severe dengue (dengue hemorrhagic fever/dengue shock syndrome).
  • To measure plasma levels of WPB constituents and assess their correlation with disease severity and complications.

Main Methods:

  • Plasma levels of von Willebrand factor antigen (VWF:Ag), VWF propeptide, osteoprotegerin (OPG), and ADAMTS-13 activity were measured in 73 Indonesian children with DHF/DSS and 17 healthy controls.
  • VWF activation factor and VWF multimer distribution were analyzed.
  • Correlations between WPB constituents and clinical markers of disease severity were assessed.

Main Results:

  • Children with DHF/DSS exhibited significantly higher plasma levels of VWF:Ag, VWF propeptide, and OPG compared to controls.
  • ADAMTS-13 activity was decreased in DHF/DSS patients, with higher VWF activation factor levels, particularly in non-survivors.
  • VWF propeptide levels correlated better with disease severity markers than VWF:Ag levels, suggesting VWF consumption.

Conclusions:

  • Severe dengue is linked to WPB exocytosis, evidenced by elevated circulating VWF:Ag, VWF propeptide, and OPG.
  • Low ADAMTS-13 activity and high VWF activation likely contribute to thrombocytopenia and dengue complications.
  • Acquired von Willebrand disease, characterized by loss of large VWF multimers, may occur during convalescence.
Abstract

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.